OIT (N = 31) | Untreated group (N = 17) | ||
---|---|---|---|
Desensitization | Two-weeks-sustained unresponsiveness | Pass OFC | |
At 1-year follow-up | 14/31 (45 %)*, # | 7/31 (21 %)**, ## | 0/17 (0 %)*,**, a |
At 2-year follow-up | 18/30 (60 %)# | 14/30 (47 %)## | |
At 3-year follow-up | 21/30 (70 %) | 16/30 (53 %) | |
At 4-year follow-up | 17/20 (85 %) | 14/20 (70 %) |